US 10378058
Diagnostic and therapeutic methods and compositions involving PTEN and breast cancer
granted A61PA61P35/00
Quick answer
US patent 10378058 (Diagnostic and therapeutic methods and compositions involving PTEN and breast cancer) held by The Board of Regents of the University of Texas System expires Mon Aug 08 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Aug 13 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 08 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61P, A61P35/00